Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2012
09/26/2012CN102690349A Quantum dot nano-particle biological probe of hepatitis B surface antigen and its preparation method and use
09/26/2012CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof
09/26/2012CN101699288B Method for detecting microcystin-LR by self-assembly based on end face of gold nano-rod
09/26/2012CN101397340B Basic orange artificial antigen synthesis and antibody preparation method
09/26/2012CN101253264B 抗血小板膜糖蛋白Ⅵ单克隆抗体 Anti-platelet membrane glycoprotein monoclonal antibody Ⅵ
09/26/2012CN101248087B Improved nanobodies(tm) against tumor necrosis factor-alpha
09/26/2012CN101186650B Antibody against secreted N-terminal peptide or C-terminal peptide of GPC3 present in blood
09/26/2012CN101128485B Monoclonal antibodies against angiopoietin-like protein 4 (ANGPTL4)
09/26/2012CN101128484B Compositions and methods relating to anti IGF-1 receptor antibodies
09/26/2012CN101001878B Interferon alpha receptor 1 antibodies and their uses
09/26/2012CN101001877B Human monoclonal antibodies against human IL-4
09/25/2012US8273859 Diagnostic agent and therapeutic agent for pancreatic cancer
09/25/2012US8273858 Polypeptide compounds for inhibiting angiogenesis and tumor growth
09/25/2012US8273787 Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions
09/25/2012US8273724 Melanoma antigens and their use in diagnostic and therapeutic methods
09/25/2012US8273705 Conversion of apoptotic proteins
09/25/2012US8273704 Use of repeat sequence protein polymers in personal care compositions
09/25/2012US8273570 Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
09/25/2012US8273548 Nucleic acids encoding a human PAP1 polypeptide
09/25/2012US8273541 Compositions and methods for detecting TLR3
09/25/2012US8273527 Viral variants
09/25/2012US8273356 Anti-IgE vaccines
09/25/2012US8273354 Anti-RSV G protein antibodies
09/25/2012US8273353 Inhibitors of vascular endothelial growth factor activity
09/25/2012US8273352 Humanized anti-factor D antibodies and uses thereof
09/25/2012US8273351 Fc receptor binding proteins
09/25/2012US8273350 Antibodies to human IL-1β
09/25/2012US8273349 Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2648109C Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine
09/25/2012CA2642542C Reagents and methods for cancer prognosis and pathological staging
09/25/2012CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
09/25/2012CA2507163C Streptococcus uberis adhesion molecule
09/25/2012CA2478049C Humanized antibodies that recognize beta amyloid peptide
09/25/2012CA2447832C Phage display libraries of human vh fragments
09/25/2012CA2429042C Pd-1 deficient mice and the use
09/25/2012CA2428438C Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
09/25/2012CA2375337C Srsv detection kit
09/25/2012CA2336236C Mutations in and genomic structure of herg - a long qt syndrome gene
09/25/2012CA2323681C Development of human monoclonal antibodies and uses thereof
09/25/2012CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses
09/25/2012CA2188061C Immunosuppressant target proteins
09/20/2012WO2012125864A2 Overcoming resistance to erbb pathway inhibitors
09/20/2012WO2012125850A1 Fc variants
09/20/2012WO2012125735A1 An integrated approach to the isolation and purification of antibodies
09/20/2012WO2012125733A2 Antibody screening methods
09/20/2012WO2012125680A1 Methods of treating vasculitis using an il-17 binding molecule
09/20/2012WO2012125652A2 Antibody and antibody mimetic for visualization and ablation of endogenous proteins
09/20/2012WO2012125623A2 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
09/20/2012WO2012125614A1 Compositions and methods for the therapy and diagnosis of influenza
09/20/2012WO2012125573A2 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers
09/20/2012WO2012125559A1 Human tissue factor antibody and uses thereof
09/20/2012WO2012125124A1 Fgfr1 antibodies and treatment of cancer
09/20/2012WO2012124764A1 Antibody production method
09/20/2012WO2012124683A1 Novel monoclonal antibody and use thereof as tag antibody
09/20/2012WO2012124334A1 Antibody, pharmaceutical composition used for treatment of breast cancer, tumor test method, and reagent for testing tumor
09/20/2012WO2012123949A1 Bi- and monospecific, asymmetric antibodies and methods of generating the same
09/20/2012WO2012123586A1 Antibodies to cd70
09/20/2012WO2012123570A1 Control of phagocytosis
09/20/2012WO2012123562A1 Diagnostic antibody assay
09/20/2012WO2012123488A1 Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase
09/20/2012WO2012122657A1 Nlrp7-based diagnosis of female reproductive conditions
09/20/2012WO2012088247A3 Anti-c5/c5a/c5adesr antibodies and fragments
09/20/2012WO2012076985A8 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
09/20/2012US20120240286 Nucleic acid promoter sequences that control gene expression in plants
09/20/2012US20120240284 Cloning and exploitation of a functional r-gene from solanum chacoense
09/20/2012US20120240248 Novel Fatty Acid Desaturase and Uses Thereof
09/20/2012US20120238731 Methods of preparation of conjugates
09/20/2012US20120238730 Integrated approach to the isolation and purification of antibodies
09/20/2012US20120238729 Modified Antibody Constant Regions
09/20/2012US20120238728 Multivalent antibodies and uses therefor
09/20/2012US20120238724 Mutated immunoglobulin-binding protein
09/20/2012US20120238478 Protein markers for the diagnosis and prognosis of ovarian and breast cancer
09/20/2012US20120237993 Polypeptides Having Cellobiohydrolase 1 Activity and Polynucleotides Encoding Same
09/20/2012US20120237975 Engineered nucleic acids and methods of use thereof
09/20/2012US20120237954 Biomarkers for prognoses of pulmonary diseases
09/20/2012US20120237948 Collagen neoepitope antibody
09/20/2012US20120237947 Glutathione S-Transferase Omega 1 Wild Type Specific Antibody
09/20/2012US20120237945 Chimeric pcsk9 proteins, cells comprising same, and assays using same
09/20/2012US20120237922 Viral Diagnostics
09/20/2012US20120237531 Topoisomerase inhibitors
09/20/2012US20120237530 Integrin alpha 8-beta 1-specific monoclonal antibody
09/20/2012US20120237529 Diagnostic antibody assay
09/20/2012US20120237528 Human Tissue Factor Antibody and Uses Thereof
09/20/2012US20120237527 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
09/20/2012US20120237526 Bace1 inhibitory antibodies
09/20/2012US20120237523 Neutralizing antibodies to hiv-1 and their use
09/20/2012US20120237521 Compositions and methods for increasing muscle growth
09/20/2012US20120237520 Boris isoforms and methods of detecting and treating disease
09/20/2012US20120237519 Pestvirus species
09/20/2012US20120237518 Anti-trop-2 antibody
09/20/2012US20120237517 Antibody Substituting for Function of Blood Coagulation Factor VIII
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237510 Anti-NKG2A Antibodies and Uses Thereof
09/20/2012US20120237507 Monovalent Antigen Binding Proteins
09/20/2012US20120237506 Antigen Binding Proteins
09/20/2012US20120237498 4-1bb binding molecules
09/20/2012US20120237493 Nucleic acids encoding a mut-t domain-containing polypeptide
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012CA2852056A1 Anti-cd40 antibodies and uses thereof
1 ... 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 ... 1494